Poseida Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PSTX and buy or sell other stocks, ETFs, and their options commission-free!About PSTX
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T.
CEOKristin Yarema, PhD
CEOKristin Yarema, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees—
Employees—
PSTX Key Statistics
Market cap925.41M
Market cap925.41M
Price-Earnings ratio-15.00
Price-Earnings ratio-15.00
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.67
52 Week high$9.67
52 Week low$2.63
52 Week low$2.63
Stock Snapshot
As of today, Poseida Therapeutics(PSTX) shares are valued at $9.50. The company's market cap stands at 925.41M, with a P/E ratio of -15.00.
On 2025-11-16, Poseida Therapeutics(PSTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
Over the past 52 weeks, Poseida Therapeutics(PSTX) stock has traded between a high of $9.67 and a low of $2.63.
Over the past 52 weeks, Poseida Therapeutics(PSTX) stock has traded between a high of $9.67 and a low of $2.63.
People also own
Based on the portfolios of people who own PSTX. This list is generated using Robinhood data, and it’s not a recommendation.